{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:14:20Z","timestamp":1791173660098,"version":"4.1.0"},"reference-count":28,"publisher":"American Association for Cancer Research (AACR)","issue":"12","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Meningiomas constitute the second most common central nervous system tumor, and yet relatively little is known about the molecular events that are important for the pathogenesis and malignant progression of these tumors. We have used serial analysis of gene expression to compare the transcriptomes of nonneoplastic meninges and meningiomas of all malignancy grades. A novel finding from this screen is the induction of three components of the Notch signaling pathway: the transcription factor, hairy and enhancer of Split1 (HES1) and two members of the Groucho\/transducin-like enhancer of Split family of corepressors, TLE2 and TLE3. TLE corepressors interact and modulate the activity of a wide range of transcriptional regulatory systems, one of which is HES1. We have shown that the transcript and protein levels of HES1, the Notch2 and Notch1 receptors and the Jagged1 ligand are induced in meningiomas of all grades, whereas induction of TLE2 and TLE3 occurs specifically in higher-grade meningiomas. Meningioma cell lines express components of the Notch signaling pathway and an inhibitor of this pathway suppresses meningioma cell survival. These results suggest that deregulated expression of the Notch pathway is a critical event in meningioma pathogenesis and that modulation of this and potentially other signaling pathways by TLE corepressors leads to a more malignant phenotype.<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-0240","type":"journal-article","created":{"date-parts":[[2005,9,15]],"date-time":"2005-09-15T21:53:09Z","timestamp":1126821189000},"page":"5070-5075","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Meningioma Transcript Profiles Reveal Deregulated Notch Signaling Pathway"],"prefix":"10.1158","volume":"65","author":[{"given":"Ileana C.","family":"Cuevas","sequence":"first","affiliation":[{"name":"1Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison L.","family":"Slocum","sequence":"additional","affiliation":[{"name":"1Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Jun","sequence":"additional","affiliation":[{"name":"1Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Costello","sequence":"additional","affiliation":[{"name":"1Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Bollen","sequence":"additional","affiliation":[{"name":"1Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Riggins","sequence":"additional","affiliation":[{"name":"2Department of Neurosurgery, Johns Hopkins Medical Center, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"McDermott","sequence":"additional","affiliation":[{"name":"1Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Lal","sequence":"additional","affiliation":[{"name":"1Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2005,6,15]]},"reference":[{"key":"2022061621025675000_B1","unstructured":"Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ. Meningiomas. In: Kleihues P, Cavenee WK, editors. Pathology and genetics: tumours of the nervous system. Lyon: IARC; 2000. p. 176\u201384."},{"key":"2022061621025675000_B2","doi-asserted-by":"crossref","unstructured":"McDermott MW. Current treatment of meningiomas. Curr Opin Neurol\u20081996; 9: 409\u201313.","DOI":"10.1097\/00019052-199612000-00002"},{"key":"2022061621025675000_B3","doi-asserted-by":"crossref","unstructured":"Kalamarides M, Niwa-Kawakita M, Leblois H, et al. Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. Genes Dev\u20082002; 16: 1060\u20135.","DOI":"10.1101\/gad.226302"},{"key":"2022061621025675000_B4","doi-asserted-by":"crossref","unstructured":"Gutmann DH, Hirbe AC, Huang ZY, Haipek CA. The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion. Neurobiol Dis\u20082001; 8: 266\u201378.","DOI":"10.1006\/nbdi.2000.0376"},{"key":"2022061621025675000_B5","doi-asserted-by":"crossref","unstructured":"Bostrom J, Meyer-Puttlitz B, Wolter M, et al. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol\u20082001; 159: 661\u20139.","DOI":"10.1016\/S0002-9440(10)61737-3"},{"key":"2022061621025675000_B6","doi-asserted-by":"crossref","unstructured":"Surace EI, Lusis E, Murakami Y, Scheithauer BW, Perry A, Gutmann DH. Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival. J Neuropathol Exp Neurol\u20082004; 63: 1015\u201327.","DOI":"10.1093\/jnen\/63.10.1015"},{"key":"2022061621025675000_B7","doi-asserted-by":"crossref","unstructured":"Surace EI, Lusis E, Haipek CA, Gutmann DH. Functional significance of S6K overexpression in meningioma progression. Ann Neurol\u20082004; 56: 295\u20138.","DOI":"10.1002\/ana.20201"},{"key":"2022061621025675000_B8","doi-asserted-by":"crossref","unstructured":"Polyak K, Riggins GJ. Gene discovery using the serial analysis of gene expression technique: implications for cancer research. J Clin Oncol\u20082001; 19: 2948\u201358.","DOI":"10.1200\/JCO.2001.19.11.2948"},{"key":"2022061621025675000_B9","doi-asserted-by":"crossref","unstructured":"Fan X, Mikolaenko I, Elhassan I, et al. Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Res\u20082004; 64: 7787\u201393.","DOI":"10.1158\/0008-5472.CAN-04-1446"},{"key":"2022061621025675000_B10","doi-asserted-by":"crossref","unstructured":"Hansson EM, Lendahl U, Chapman G. Notch signaling in development and disease. Semin Cancer Biol\u20082004; 14: 320\u20138.","DOI":"10.1016\/j.semcancer.2004.04.011"},{"key":"2022061621025675000_B11","doi-asserted-by":"crossref","unstructured":"Purow BW, Haque RM, Noel MW, et al. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res\u20082005; 65: 2353\u201363.","DOI":"10.1158\/0008-5472.CAN-04-1890"},{"key":"2022061621025675000_B12","doi-asserted-by":"crossref","unstructured":"Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol\u20082002; 61: 215\u201325.","DOI":"10.1093\/jnen\/61.3.215"},{"key":"2022061621025675000_B13","unstructured":"Lal A, Glazer CA, Martinson HM, et al. Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion. Cancer Res\u20082002; 62: 3335\u20139."},{"key":"2022061621025675000_B14","doi-asserted-by":"crossref","unstructured":"Gupta N, Lamborn K, Deen DF. A statistical approach for analyzing clonogenic survival data. Radiat Res\u20081996; 145: 636\u201340.","DOI":"10.2307\/3579284"},{"key":"2022061621025675000_B15","doi-asserted-by":"crossref","unstructured":"Blaumueller CM, Qi H, Zagouras P, Artavanis-Tsakonas S. Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. Cell\u20081997; 90: 281\u201391.","DOI":"10.1016\/S0092-8674(00)80336-0"},{"key":"2022061621025675000_B16","doi-asserted-by":"crossref","unstructured":"Pear WS, Aster JC. T cell acute lymphoblastic leukemia\/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Curr Opin Hematol\u20082004; 11: 426\u201333.","DOI":"10.1097\/01.moh.0000143965.90813.70"},{"key":"2022061621025675000_B17","doi-asserted-by":"crossref","unstructured":"Nicolas M, Wolfer A, Raj K, et al. Notch1 functions as a tumor suppressor in mouse skin. Nat Genet\u20082003; 33: 416\u201321.","DOI":"10.1038\/ng1099"},{"key":"2022061621025675000_B18","doi-asserted-by":"crossref","unstructured":"Talora C, Sgroi DC, Crum CP, Dotto GP. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6\/E7 expression and late steps of malignant transformation. Genes Dev\u20082002; 16: 2252\u201363.","DOI":"10.1101\/gad.988902"},{"key":"2022061621025675000_B19","doi-asserted-by":"crossref","unstructured":"Jundt F, Anagnostopoulos I, Forster R, Mathas S, Stein H, Dorken B. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood\u20082002; 99: 3398\u2013403.","DOI":"10.1182\/blood.V99.9.3398"},{"key":"2022061621025675000_B20","doi-asserted-by":"crossref","unstructured":"Robbins J, Blondel BJ, Gallahan D, Callahan R. Mouse mammary tumor gene int-3: a member of the notch gene family transforms mammary epithelial cells. J Virol\u20081992; 66: 2594\u20139.","DOI":"10.1128\/jvi.66.4.2594-2599.1992"},{"key":"2022061621025675000_B21","doi-asserted-by":"crossref","unstructured":"Ellisen LW, Bird J, West DC, et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell\u20081991; 66: 649\u201361.","DOI":"10.1016\/0092-8674(91)90111-B"},{"key":"2022061621025675000_B22","doi-asserted-by":"crossref","unstructured":"Chen G, Courey AJ. Groucho\/TLE family proteins and transcriptional repression. Gene\u20082000; 249: 1\u201343.","DOI":"10.1016\/S0378-1119(00)00161-X"},{"key":"2022061621025675000_B23","doi-asserted-by":"crossref","unstructured":"Midorikawa Y, Tsutsumi S, Taniguchi H, et al. Identification of genes associated with dedifferentiation of hepatocellular carcinoma with expression profiling analysis. Jpn J Cancer Res\u20082002; 93: 636\u201343.","DOI":"10.1111\/j.1349-7006.2002.tb01301.x"},{"key":"2022061621025675000_B24","doi-asserted-by":"crossref","unstructured":"Sonderegger CK, Vogt PK. Binding of the corepressor TLE1 to Qin enhances Qin-mediated transformation of chicken embryo fibroblasts. Oncogene\u20082003; 22: 1749\u201357.","DOI":"10.1038\/sj.onc.1206308"},{"key":"2022061621025675000_B25","doi-asserted-by":"crossref","unstructured":"Grbavec D, Lo R, Liu Y, Stifani S. Transducin-like Enhancer of split 2, a mammalian homologue of Drosophila Groucho, acts as a transcriptional repressor, interacts with Hairy\/Enhancer of split proteins, and is expressed during neuronal development. Eur J Biochem\u20081998; 258: 339\u201349.","DOI":"10.1046\/j.1432-1327.1998.2580339.x"},{"key":"2022061621025675000_B26","doi-asserted-by":"crossref","unstructured":"Nickoloff BJ, Osborne BA, Miele L. Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene\u20082003; 22: 6598\u2013608.","DOI":"10.1038\/sj.onc.1206758"},{"key":"2022061621025675000_B27","doi-asserted-by":"crossref","unstructured":"Qin JZ, Stennett L, Bacon P, et al. p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas. Mol Cancer Ther\u20082004; 3: 895\u2013902.","DOI":"10.1158\/1535-7163.895.3.8"},{"key":"2022061621025675000_B28","doi-asserted-by":"crossref","unstructured":"Murakami D, Okamoto I, Nagano O, et al. Presenilin-dependent \u03b3-secretase activity mediates the intramembranous cleavage of CD44. Oncogene\u20082003; 22: 1511\u20136.","DOI":"10.1038\/sj.onc.1206298"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/12\/5070\/2535085\/5070-5075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/12\/5070\/2535085\/5070-5075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T22:03:50Z","timestamp":1655417030000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/65\/12\/5070\/518409\/Meningioma-Transcript-Profiles-Reveal-Deregulated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,15]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2005,6,15]]},"published-print":{"date-parts":[[2005,6,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-0240","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,15]]}}}